Literature DB >> 25926378

mRNAs and miRNAs in whole blood associated with lung hyperplasia, fibrosis, and bronchiolo-alveolar adenoma and adenocarcinoma after multi-walled carbon nanotube inhalation exposure in mice.

Brandi N Snyder-Talkington1, Chunlin Dong2, Linda M Sargent1, Dale W Porter1, Lauren M Staska3, Ann F Hubbs1, Rebecca Raese2, Walter McKinney1, Bean T Chen1, Lori Battelli1, David T Lowry1, Steven H Reynolds1, Vincent Castranova4, Yong Qian1, Nancy L Guo2.   

Abstract

Inhalation exposure to multi-walled carbon nanotubes (MWCNT) in mice results in inflammation, fibrosis and the promotion of lung adenocarcinoma; however, the molecular basis behind these pathologies is unknown. This study determined global mRNA and miRNA profiles in whole blood from mice exposed by inhalation to MWCNT that correlated with the presence of lung hyperplasia, fibrosis, and bronchiolo-alveolar adenoma and adenocarcinoma. Six-week-old, male, B6C3F1 mice received a single intraperitoneal injection of either the DNA-damaging agent methylcholanthrene (MCA, 10 µg g(-1) body weight) or vehicle (corn oil). One week after injections, mice were exposed by inhalation to MWCNT (5 mg m(-3), 5 hours per day, 5 days per week) or filtered air (control) for a total of 15 days. At 17 months post-exposure, mice were euthanized and examined for the development of pathological changes in the lung, and whole blood was collected and analyzed using microarray analysis for global mRNA and miRNA expression. Numerous mRNAs and miRNAs in the blood were significantly up- or down-regulated in animals developing pathological changes in the lung after MCA/corn oil administration followed by MWCNT/air inhalation, including fcrl5 and miR-122-5p in the presence of hyperplasia, mthfd2 and miR-206-3p in the presence of fibrosis, fam178a and miR-130a-3p in the presence of bronchiolo-alveolar adenoma, and il7r and miR-210-3p in the presence of bronchiolo-alveolar adenocarcinoma, among others. The changes in miRNA and mRNA expression, and their respective regulatory networks, identified in this study may potentially serve as blood biomarkers for MWCNT-induced lung pathological changes.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  MCA; MWCNT; adenocarcinoma; fibrosis; mRNA; miRNA

Mesh:

Substances:

Year:  2015        PMID: 25926378      PMCID: PMC4418205          DOI: 10.1002/jat.3157

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  78 in total

1.  Hypoxic induction of receptor activity-modifying protein 2 alters regulation of pulmonary endothelin-1 by adrenomedullin: induction under normoxia versus inhibition under hypoxia.

Authors:  Thomas Dschietzig; Christoph Richter; Louay Asswad; Gert Baumann; Karl Stangl
Journal:  J Pharmacol Exp Ther       Date:  2007-01-24       Impact factor: 4.030

2.  What differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosis.

Authors:  Robert M Strieter
Journal:  Proc Am Thorac Soc       Date:  2008-04-15

Review 3.  Molecular biomarkers in idiopathic pulmonary fibrosis.

Authors:  Brett Ley; Kevin K Brown; Harold R Collard
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-09-26       Impact factor: 5.464

4.  Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology.

Authors:  C Vancheri; M Failla; N Crimi; G Raghu
Journal:  Eur Respir J       Date:  2010-03       Impact factor: 16.671

5.  Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.

Authors:  Marcin Imielinski; Alice H Berger; Peter S Hammerman; Bryan Hernandez; Trevor J Pugh; Eran Hodis; Jeonghee Cho; James Suh; Marzia Capelletti; Andrey Sivachenko; Carrie Sougnez; Daniel Auclair; Michael S Lawrence; Petar Stojanov; Kristian Cibulskis; Kyusam Choi; Luc de Waal; Tanaz Sharifnia; Angela Brooks; Heidi Greulich; Shantanu Banerji; Thomas Zander; Danila Seidel; Frauke Leenders; Sascha Ansén; Corinna Ludwig; Walburga Engel-Riedel; Erich Stoelben; Jürgen Wolf; Chandra Goparju; Kristin Thompson; Wendy Winckler; David Kwiatkowski; Bruce E Johnson; Pasi A Jänne; Vincent A Miller; William Pao; William D Travis; Harvey I Pass; Stacey B Gabriel; Eric S Lander; Roman K Thomas; Levi A Garraway; Gad Getz; Matthew Meyerson
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

6.  System-based identification of toxicity pathways associated with multi-walled carbon nanotube-induced pathological responses.

Authors:  Brandi N Snyder-Talkington; Julian Dymacek; Dale W Porter; Michael G Wolfarth; Robert R Mercer; Maricica Pacurari; James Denvir; Vincent Castranova; Yong Qian; Nancy L Guo
Journal:  Toxicol Appl Pharmacol       Date:  2013-07-08       Impact factor: 4.219

7.  Amplified centrosomes in breast cancer: a potential indicator of tumor aggressiveness.

Authors:  Antonino B D'Assoro; Susan L Barrett; Christopher Folk; Vivian C Negron; Kelly Boeneman; Robert Busby; Clark Whitehead; Franca Stivala; Wilma L Lingle; Jeffrey L Salisbury
Journal:  Breast Cancer Res Treat       Date:  2002-09       Impact factor: 4.872

8.  HiJAK'd Signaling; the STAT3 Paradox in Senescence and Cancer Progression.

Authors:  Damian J Junk; Benjamin L Bryson; Mark W Jackson
Journal:  Cancers (Basel)       Date:  2014-03-26       Impact factor: 6.639

9.  Extrapulmonary transport of MWCNT following inhalation exposure.

Authors:  Robert R Mercer; James F Scabilloni; Ann F Hubbs; Liying Wang; Lori A Battelli; Walter McKinney; Vincent Castranova; Dale W Porter
Journal:  Part Fibre Toxicol       Date:  2013-08-09       Impact factor: 9.400

10.  Genotoxicity of multi-walled carbon nanotubes at occupationally relevant doses.

Authors:  Katelyn J Siegrist; Steven H Reynolds; Michael L Kashon; David T Lowry; Chenbo Dong; Ann F Hubbs; Shih-Houng Young; Jeffrey L Salisbury; Dale W Porter; Stanley A Benkovic; Michael McCawley; Michael J Keane; John T Mastovich; Kristin L Bunker; Lorenzo G Cena; Mark C Sparrow; Jacqueline L Sturgeon; Cerasela Zoica Dinu; Linda M Sargent
Journal:  Part Fibre Toxicol       Date:  2014-01-30       Impact factor: 9.400

View more
  19 in total

1.  Fibrosis biomarkers in workers exposed to MWCNTs.

Authors:  Liliya M Fatkhutdinova; Timur O Khaliullin; Olga L Vasil'yeva; Ramil R Zalyalov; Ilshat G Mustafin; Elena R Kisin; M Eileen Birch; Naveena Yanamala; Anna A Shvedova
Journal:  Toxicol Appl Pharmacol       Date:  2016-02-20       Impact factor: 4.219

2.  Upregulated has-miR-4516 as a potential biomarker for early diagnosis of dust-induced pulmonary fibrosis in patients with pneumoconiosis.

Authors:  Ruixue Huang; Ting Yu; Ying Li; Jianan Hu
Journal:  Toxicol Res (Camb)       Date:  2018-02-08       Impact factor: 3.524

Review 3.  Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans.

Authors:  Eileen D Kuempel; Marie-Claude Jaurand; Peter Møller; Yasuo Morimoto; Norihiro Kobayashi; Kent E Pinkerton; Linda M Sargent; Roel C H Vermeulen; Bice Fubini; Agnes B Kane
Journal:  Crit Rev Toxicol       Date:  2016-08-18       Impact factor: 5.635

4.  Comparative analysis of lung and blood transcriptomes in mice exposed to multi-walled carbon nanotubes.

Authors:  Timur O Khaliullin; Naveena Yanamala; Mackenzie S Newman; Elena R Kisin; Liliya M Fatkhutdinova; Anna A Shvedova
Journal:  Toxicol Appl Pharmacol       Date:  2020-01-22       Impact factor: 4.219

Review 5.  Biological monitoring of workers exposed to engineered nanomaterials.

Authors:  P Schulte; V Leso; M Niang; I Iavicoli
Journal:  Toxicol Lett       Date:  2018-06-18       Impact factor: 4.372

6.  Integrated Analysis of Dysregulated ncRNA and mRNA Expression Profiles in Humans Exposed to Carbon Nanotubes.

Authors:  Anna A Shvedova; Naveena Yanamala; Elena R Kisin; Timur O Khailullin; M Eileen Birch; Liliya M Fatkhutdinova
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

Review 7.  Mechanisms of lung fibrosis induced by carbon nanotubes: towards an Adverse Outcome Pathway (AOP).

Authors:  Giulia Vietti; Dominique Lison; Sybille van den Brule
Journal:  Part Fibre Toxicol       Date:  2016-02-29       Impact factor: 9.400

8.  MiR-130a-3p inhibits the viability, proliferation, invasion, and cell cycle, and promotes apoptosis of nasopharyngeal carcinoma cells by suppressing BACH2 expression.

Authors:  Xin Chen; Bo Yue; Changming Zhang; Meihao Qi; Jianhua Qiu; Ye Wang; Jun Chen
Journal:  Biosci Rep       Date:  2017-06-08       Impact factor: 3.840

9.  miRNA-378a as a key regulator of cardiovascular health following engineered nanomaterial inhalation exposure.

Authors:  Quincy A Hathaway; Andrya J Durr; Danielle L Shepherd; Mark V Pinti; Ashley N Brandebura; Cody E Nichols; Amina Kunovac; William T Goldsmith; Sherri A Friend; Alaeddin B Abukabda; Garrett K Fink; Timothy R Nurkiewicz; John M Hollander
Journal:  Nanotoxicology       Date:  2019-02-01       Impact factor: 5.913

10.  Shuanghuang Shengbai granule cures myelosuppression and suppresses lung cancer progression: mechanism and therapeutic targets from the aspect of microRNAs.

Authors:  Shuang Wang; Zhenye Xu; Lifang Wang
Journal:  Oncotarget       Date:  2017-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.